Kun Zeng

Papers

Total Citations

158

H-Index

About

Kun Zeng is a pioneering figure in clinical laboratory automation and immunoassay technology, best known for developing the Abbott IMx—a groundbreaking benchtop immunochemistry analyzer that revolutionized diagnostic testing. His most-cited work, a 1988 paper describing the IMx system (158 citations), introduced the novel Microparticle capture Enzyme ImmunoAssay (MEIA) technology, enabling automated, high-throughput detection of high-molecular-mass analytes. This innovation, alongside fluorescence polarization immunoassay capabilities, dramatically improved the speed, precision, and accessibility of clinical lab testing. Zeng’s contributions laid the foundation for modern automated immunoassay platforms, directly impacting patient care by reducing turnaround times and human error. His work remains a cornerstone in clinical chemistry, cited extensively in studies on lab automation and immunoassay design. Beyond this landmark achievement, Zeng’s research has influenced the evolution of point-of-care diagnostics and continues to inspire engineers and clinicians seeking to bridge technology and medicine. His legacy endures in every automated immunoassay analyzer that builds on the MEIA principle.